Evidence map›Paper›PMID 27998958›Full record

ArticleEndocrine-related cancer2017

Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.

Shuk-Mei Ho, Rahul Rao, Sarah To, Emma Schoch, Pheruza Tarapore

Open access · bronzeAbstract read
In one paragraph

Article in Endocrine-related cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Epidemiology of Prostate Cancer.World journal of oncology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Shuk-Mei HoDepartment of Environmental HealthUniversity of Cincinnati Medical Center, Cincinnati, Ohio, USA shuk-mei.ho@uc.edu pheruza.tarapore@uc.edu.
Rahul RaoDepartment of Environmental HealthUniversity of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Sarah ToDepartment of Environmental HealthUniversity of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Emma SchochDepartment of Environmental HealthUniversity of Cincinnati Medical Center, Cincinnati, Ohio, USA.
Pheruza TaraporeDepartment of Environmental HealthUniversity of Cincinnati Medical Center, Cincinnati, Ohio, USA shuk-mei.ho@uc.edu pheruza.tarapore@uc.edu.
University of Cincinnati · USUniversity of Cincinnati Medical Center · USMonash University · AU

Funding

REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
Susceptible Window of High Fat Diet/Bisphenol A Programming of Breast Cancer RiskU01ES019480 · NIEHS · UNIVERSITY OF CINCINNATI · PI HO, SHUK-MEI · 2010 to 2014
$2.2M
G-protein coupled receptor-30(GPR30):a putative new therapeutic target for PCaI01BX000675 · VA · CINCINNATI VA MEDICAL CENTER RESEARCH · PI HO, SHUK-MEI · 2011 to 2019
–
BLRD VA I01 BX000675NIEHS NIH HHS P30 ES006096NIEHS NIH HHS U01 ES019480
6 · The paper itself

Abstract

Humans are increasingly exposed to structural analogues of bisphenol A (BPA), as BPA is being replaced by these compounds in BPA-free consumer products. We have previously shown that chronic and developmental exposure to BPA is associated with increased prostate cancer (PCa) risk in human and animal models. Here, we examine whether exposure of PCa cells (LNCaP, C4-2) to low-dose BPA and its structural analogues (BPS, BPF, BPAF, TBBPA, DMBPA and TMBPA) affects centrosome amplification (CA), a hallmark of cancer initiation and progression. We found that exposure to BPA, BPS, DMBPA and TBBPA, in descending order, increased the number of cells with CA, in a non-monotonic dose-response manner. Furthermore, cells treated with BPA and their analogues initiated centrosome duplication at 8 h after release from serum starvation, significantly earlier in G-1 phase than control cells. This response was attended by earlier release of nucleophosmin from unduplicated centrosomes. BPA-exposed cells exhibited increased expression of cyclin-dependent kinase CDK6 and decreased expression of CDK inhibitors (p21

Indexed as

Benzhydryl CompoundsBisphenol A CompoundsCell Line, TumorCentrosomeEndocrine DisruptorsGene Expression Regulation, NeoplasticHumansMaleMicrotubulesPhenolsProstatic NeoplasmsBenzhydryl Compoundsbisphenol ABisphenol A CompoundsEndocrine DisruptorsPhenolsbisphenol A analoguesBPABPFBPScentriole duplicationDMBPAendocrine-disrupting chemicalsprostate cancerTBBPATMBPA

Identifiers

PMID27998958
PMCPMC5226663
OpenAlexW2567048498

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.